+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
544549 EARKART

Earkart Share Price

 

 

Earkart live price: ₹132.95. It opened at ₹144 vs previous close ₹130; intraday high/low: ₹144/₹125. The 50 DMA stands at ₹137.58.

Earkart Performance

  • Today's Low
  • ₹125
  • Today's High
  • ₹144
  • 52 Week Low
  • ₹104
  • 52 Week High
  • ₹266
  • Open Price₹144
  • Previous Close₹130
  • Volume11,000
  • 50 DMA₹137.58
  • 100 DMA₹155.28
  • 200 DMA-

Earkart Chart

Investment Returns

  • Over 1 Month -10.62%
  • Over 3 Month + 10.79%
  • Over 6 Month -26.53%

Smart Investing Starts Here Start SIP with Earkart for Steady Growth!

Invest Now

Earkart Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 37.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 183
  • P/B Ratio
  • 2.8
  • Average True Range
  • 10.27
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -3.56
  • RSI
  • 49.2
  • MFI
  • 46.44

Earkart Financials

Earkart Technicals

EMA & SMA

Current Price
₹132.95
+ 2.95 (2.27%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 7
  • 20 Day
  • ₹129.50
  • 50 Day
  • ₹137.60
  • 100 Day
  • ₹155.30
  • 200 Day
  • -

Resistance and Support

130 Pivot Speed
  • R3 130.00
  • R2 130.00
  • R1 130.00
  • S1 130.00
  • S2 130.00
  • S3 130.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

earKART delivers advanced hearing solutions across India by partnering with global hearing aid brands. It offers products like hearing aids, test systems, batteries, and mobility aids, ensuring accessibility from cities to remote areas through a unified, technology-driven platform.

Earkart Ltd has an operating revenue of Rs. 120.69 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 13% is healthy, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 137 indicates it belongs to a poor industry group of Medical-Systems/Equip and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Earkart Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results & A.G.M.
2026-03-30 Others Inter-alia, to consider 1. Variation in the Objects/terms of utilization of the Initial Public Offering (IPO) proceeds and extension of time limit for utilization of the IPO proceeds.
2025-11-14 Half Yearly Results & Others Inter-alia, to consider 1. To approve and authorise for the In-principle application for the issuance of ESOP. To defer vesting right of ESOP Options. 2. incorporation of wholly owned subsidiary outside India. 3. Other business matters.

Earkart Shareholding Pattern

57.34%
0%
16.94%
25.72%

Earkart FAQs

Earkart share price is ₹132 As on 18 June, 2026 | 15:54

The Market Cap of Earkart is ₹182.9 Cr As on 18 June, 2026 | 15:54

The P/E ratio of Earkart is 37.1 As on 18 June, 2026 | 15:54

The PB ratio of Earkart is 2.8 As on 18 June, 2026 | 15:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23